On this page
David J Wescott
Insider
First SEC filing: June 27, 2019 · Latest: June 27, 2019
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 25, 2019 | CME | A | 606 | · | · | 75,859 Direct | +0.81% | Acquired | (price as of 2026-10-06) |
| Sept. 25, 2018 | CME | A | 87 | · | · | 75,253 Direct | +0.12% | Acquired | (price as of 2026-10-06) |
| June 25, 2018 | CME | A | 601 | · | · | 75,166 Direct | +0.81% | Acquired | (price as of 2026-10-06) |
| June 26, 2017 | CME | A | 1,294 | · | · | 74,565 Direct | +1.77% | Acquired | (price as of 2026-10-06) |
| June 27, 2016 | CME | A | 1,075 | · | · | 73,271 Direct | +1.49% | Acquired | (price as of 2026-10-06) |
| Sept. 16, 2015 | CME | P | 1 | $95.37 | $95 | 1 Direct | · | Acquired | 183.3% (price as of 2026-10-06) |
| June 25, 2015 | CME | A | 1,064 | · | · | 72,196 Direct | +1.50% | Acquired | (price as of 2026-10-06) |
| March 2, 2015 | CME | P | 2 | $95.42 | $191 | 3 Direct | +200.00% | Acquired | 183.1% (price as of 2026-10-06) |
| Aug. 25, 2014 | CME | A | 331 | · | · | 71,132 Direct | +0.47% | Acquired | (price as of 2026-10-06) |
| June 25, 2014 | CME | A | 1,062 | · | · | 70,801 Direct | +1.52% | Acquired | (price as of 2026-10-06) |
| June 25, 2013 | CME | A | 982 | · | · | 70,234 Direct | +1.42% | Acquired | (price as of 2026-10-06) |
| June 25, 2012 | CME | A | 281 | · | · | 13,848 Direct | +2.07% | Acquired | (price as of 2026-10-06) |
| Sept. 14, 2011 | CME | P | 1 | $269.62 | $270 | 1 Direct | · | Acquired | 401.0% (price as of 2026-10-06) |
| June 27, 2011 | CME | A | 267 | · | · | 13,567 Direct | +2.01% | Acquired | (price as of 2026-10-06) |
| May 25, 2010 | CME | A | 241 | · | · | 13,300 Direct | +1.85% | Acquired | (price as of 2026-10-06) |
| May 26, 2009 | CME | A | 247 | · | · | 13,059 Direct | +1.93% | Acquired | (price as of 2026-10-06) |
| May 27, 2008 | CME | A | 221 | · | · | 12,812 Direct | +1.76% | Acquired | (price as of 2026-10-06) |
| May 25, 2007 | CME | A | 171 | · | · | 12,591 Direct | +1.38% | Acquired | (price as of 2026-10-06) |
| Aug. 25, 2006 | CME | A | 59 | · | · | 12,420 Direct | +0.48% | Acquired | (price as of 2026-10-06) |
| May 25, 2006 | CME | A | 121 | · | · | 12,361 Direct | +0.99% | Acquired | (price as of 2026-10-06) |
| May 25, 2005 | CME | A | 142 | · | · | 12,240 Direct | +1.17% | Acquired | (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.